Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Lestaurtinib: a multi-targeted FLT3 inhibitor.

Lestaurtinib: a multi-targeted FLT3 inhibitor. Expert Rev Hematol. 2009 Feb; 2(1):17-26.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.